OBJECTIVE: To assess knowledge of and attitudes towards human papillomavirus (HPV), Pap testing, and the HPV vaccine. METHODS: In a multicenter U.S. cohort study, women with the human immunodeficiency virus (HIV) and at-risk comparison women completed 44-item standardized self-report questionnaires exploring their knowledge of cervical cancer prevention, HPV, and HPV vaccination. Results were correlated with demographic variables, measures of education and attention, and medical factors. Data were clustered using principal component analysis. Significant associations were assessed in multivariable models. RESULTS: Among 1588 women, HIV seropositive women better understood facts about cervical cancer prevention and HPV than seronegative women, but both had substantial knowledge deficits. Almost all women considered Pap testing important, although 53% of HIV seropositive and 48% of seronegative women considered cervical cancer not preventable (P=0.21). Only 44% of HIV seropositive women knew Paps assess the cervix, versus 42% of HIV seronegative women (P=0.57). Both groups understood that HPV causes genital warts and cervical cancer (67% of HIV seropositive vs. 55% of seronegative women, P=0.002). About half of both groups considered HPV vaccination extremely important for cervical cancer prevention. HIV seronegative women were more likely to report learning of HPV vaccination through advertising than from clinicians (81% vs. 64%, P<0.0001). CONCLUSION: High risk women need effective education about cervical cancer prevention, HPV, and HPV vaccination. Copyright 2010 Elsevier Inc. All rights reserved.
OBJECTIVE: To assess knowledge of and attitudes towards human papillomavirus (HPV), Pap testing, and the HPV vaccine. METHODS: In a multicenter U.S. cohort study, women with the human immunodeficiency virus (HIV) and at-risk comparison women completed 44-item standardized self-report questionnaires exploring their knowledge of cervical cancer prevention, HPV, and HPV vaccination. Results were correlated with demographic variables, measures of education and attention, and medical factors. Data were clustered using principal component analysis. Significant associations were assessed in multivariable models. RESULTS: Among 1588 women, HIV seropositive women better understood facts about cervical cancer prevention and HPV than seronegative women, but both had substantial knowledge deficits. Almost all women considered Pap testing important, although 53% of HIV seropositive and 48% of seronegative women considered cervical cancer not preventable (P=0.21). Only 44% of HIV seropositive women knew Paps assess the cervix, versus 42% of HIV seronegative women (P=0.57). Both groups understood that HPV causes genital warts and cervical cancer (67% of HIV seropositive vs. 55% of seronegative women, P=0.002). About half of both groups considered HPV vaccination extremely important for cervical cancer prevention. HIV seronegative women were more likely to report learning of HPV vaccination through advertising than from clinicians (81% vs. 64%, P<0.0001). CONCLUSION: High risk women need effective education about cervical cancer prevention, HPV, and HPV vaccination. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Kathleen Ell; Betsy Vourlekis; Laila Muderspach; Jan Nissly; Deborah Padgett; Diana Pineda; Olga Sarabia; Pey-Jiuan Lee Journal: J Womens Health Gend Based Med Date: 2002-09
Authors: H E Cejtin; E Komaroff; L S Massad; A Korn; J B Schmidt; D Eisenberger-Matiyahu; E Stier Journal: J Acquir Immune Defic Syndr Date: 1999-11-01 Impact factor: 3.731
Authors: L S Massad; L Ahdieh; L Benning; H Minkoff; R M Greenblatt; H Watts; P Miotti; K Anastos; M Moxley; L I Muderspach; S Melnick Journal: J Acquir Immune Defic Syndr Date: 2001-08-15 Impact factor: 3.731
Authors: Gilbert G G Donders; Gert Bellen; Ann Declerq; Judith Berger; Thierry Van Den Bosch; Ine Riphagen; Marcel Verjans Journal: Eur J Obstet Gynecol Reprod Biol Date: 2009-05-05 Impact factor: 2.435
Authors: L Stewart Massad; Eric C Seaberg; D Heather Watts; Nancy A Hessol; Sandra Melnick; Pincas Bitterman; Kathryn Anastos; Sylvia Silver; Alexandra M Levine; Howard Minkoff Journal: AIDS Date: 2004-01-02 Impact factor: 4.177
Authors: Lisa T Wigfall; Shalanda A Bynum; Heather M Brandt; Daniela B Friedman; Sharon M Bond; Gweneth B Lazenby; Donna L Richter; Saundra H Glover; James R Hébert Journal: J Cancer Educ Date: 2015-06 Impact factor: 2.037
Authors: L Stewart Massad; Charlesnika T Evans; Kathleen M Weber; Johanna L Goderre; Nancy A Hessol; Donna Henry; Christine Colie; Howard D Strickler; D Heather Watts; Tracey E Wilson Journal: Obstet Gynecol Date: 2010-10 Impact factor: 7.661
Authors: L Stewart Massad; Kathleen M Weber; Tracey E Wilson; Johanna L Goderre; Nancy A Hessol; Donna Henry; Christine Colie; Howard D Strickler; Alexandra M Levine; D Heather Watts; Charlesnika T Evans Journal: J Low Genit Tract Dis Date: 2012-04 Impact factor: 1.925
Authors: L Stewart Massad; Nancy A Hessol; Teresa M Darragh; Howard Minkoff; Christine Colie; Rodney L Wright; Mardge Cohen; Eric C Seaberg Journal: Int J Cancer Date: 2017-07-17 Impact factor: 7.396